Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools.
Intuitive Surgical stock last closed at $394.51, up 0.22% from the previous day, and has decreased 18.72% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.21 percentage points. Intuitive Surgical stock is currently +20.07% from its 52-week low of $328.57, and -34.67% from its 52-week high of $603.88.
As of Aug 14, 2026, there are 353.28M ISRG shares outstanding. The market cap of ISRG is $139.37B. In the last 24 hours, 1.99M ISRG shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ISRG shares.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal information so you can invest in ISRG today.
Now that you have finished signing up on the best stock app for beginners, you need to deposit funds:
Check out the video below to see the process of depositing funds into your brokerage account.
After you have identified the best place to buy Intuitive Surgical stock, it's crucial to research their stock prior to investing, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ISRG's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ISRG's intrinsic value.
Using relative valuations ratios:
You can access additional valuation analysis on ISRG's stock here.
Out of 23 Wall Street analysts who give recommendations on ISRG, the consensus analyst rating on Intuitive Surgical is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Robbie Marcus, a top 21% analyst from JP Morgan maintains ISRG with a strong buy rating and lowers their ISRG price target from $550.00 to $450.00, on Jul 17, 2026.
Anthony Petrone, a top 6% analyst from Mizuho maintains ISRG with a hold rating and lowers their ISRG price target from $500.00 to $400.00, on Jul 17, 2026.
Larry Biegelsen, a top 12% analyst from Wells Fargo maintains ISRG with a strong buy rating and lowers their ISRG price target from $654.00 to $487.00, on Jul 17, 2026.
Mathew Blackman, a top 18% analyst from TD Cowen maintains ISRG with a strong buy rating and lowers their ISRG price target from $520.00 to $485.00, on Jul 17, 2026.
TD Cowen's Mathew Blackman lowered their price target on Intuitive Surgical (NASDAQ: ISRG) by 6.7% from $520 to $485 on 2026/07/17. The analyst maintained their Strong Buy rating on the stock.
Intuitive Surgical reported its Q2 2026 earnings.
Blackman predicted that the stock will be pressured in the near future, citing management's comments about postponed U.S. procedures related to the Affordable Care Act and uncertainty surrounding Extended Use instruments in 2027.
For Q2 2026, Intuitive Surgical reported:
Management did not provide EPS and revenue guidance in its press release.
CEO Dave Rosa commented: “We are pleased with company performance this quarter, which reflects the strength of our portfolio – from da Vinci and Ion to our growing digital solutions.
“Our commitment to customers around the world – our north star – remains the same: helping them deliver better patient outcomes, better patient and care team experiences, lower costs, and broader access to minimally invasive care.”
Vijay Kumar, a top 17% analyst from Evercore ISI Group maintains ISRG with a hold rating and lowers their ISRG price target from $430.00 to $375.00, on Jul 17, 2026.
You can dig deeper into what analysts are forecasting on the Intuitive Surgical stock forecast page.
Last year, ISRG earnings were $3.14B. During the past five year, ISRG's earnings have grown by 14.03% per year. This was faster than the Medical Instruments & Supplies industry average of 6%.
Last year, ISRG revenue was $11.03B. In the last 5 year, ISRG's revenue has gone up by 16.4% per year. This was faster than the Medical Instruments & Supplies industry average of 10.75%.
Learn more about ISRG's earnings and revenue performance here.
In the last 12 months, insiders at ISRG have sold more shares than they have bought.
Gary S. Guthart, Director of ISRG, was the latest ISRG insider to sell. They sold $4,000,000.00 worth of ISRG stock on Aug 11, 2026.
Get more info about who owns ISRG stock here.
No, Intuitive Surgical doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main options:
Press the Open button and eToro will execute the order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Now that you own some ISRG shares, you'll want to keep up with your new company.
Start a watchlist to track your ISRG stock.
To reiterate, here are the 6 steps to buy stock in Intuitive Surgical:
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Intuitive Surgical, hit the button below to create your watchlist.